Erythrocyte sodium-lithium countertransport in non-modulating offspring and essential hypertensive individuals: Response to enalapril

Hypertension

Volumn 30, Issue 1, 1997, Pages 99-105

  Sánchez, Ramiro A ^b   Giménez, María I ^c   Migliorini, Mercedes ^c   Giannone, Carlos ^c   Ramírez, Agustín J ^c   Weder, Alan B ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^c NONE

Author keywords

Enalapril; Erythrocytes; Hypertension, non modulating; Na+ K+ exchanging ATPase; Sodium, dietary

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ENALAPRIL;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; KIDNEY BLOOD FLOW; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0343329820     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.1.99     Document Type: Article

References (41)

1. MacGregor GA. Sodium is more important than calcium in essential hypertension. Hypertension. 1985;7:628-637.
2. Weinberger NH. Salt sensitivity as a predictor of hypertension. Am J Hypertens. 1991;4:615s-616s.
3. Stamler J, Rose G, Elliot P, Dyer A, Marmot M, Kesteloot P, Stamler R, for the INTERSALT Cooperative Research Group. Findings of the international cooperative INTERSALT study. Hypertension. 1991;17(suppl I):I-9-I-15.
4. Takeshita A, Imaizumi T, Ashihara T, Nakamura M. Characteristics of responses to salt loading and deprivation in hypertensive subjects. Circ Res. 1982;51:457-464.
5. Sullivan JM, Prewitt RL, Ratts TE, Josephs JA, Connors MJ. Hemodynamic characteristics of sodium sensitive human subjects. Hypertension. 1987;9:398-406.
6. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension. 1986;8(suppl II):II-127-II-134.
7. Dahl LH, Heine M, Thompson K. Genetic influence of the kidneys on blood pressure: evidence from chronic renal homographs in rats with opposite predisposition to hypertension. Circ Res. 1974;34: 94-101.
8. Dahl LH. Salt and hypertension. Am J Clin Nutr. 1972;25:231-244.
9. Rapp JP, Wang SM, Dene H. A genetic polymorphism in the renin gene of Dahl rats co-segregates with blood pressure. Science. 1989; 243:542-544.
10. Hilbert P, Lindpaintner K, Beckmann JS, Serikawa T, Soubrier F, Dubay C, Cartwright P, De Gouyon B, Julier C, Takahasi S, Vincent M, Ganten D, Georges M, Lathrop GM. Chromosomal mapping of two genetic loci associated with blood pressure regulation in hereditary hypertensive rats. Nature. 1991;353:521-529.
11. Jacob HJ, Lindpaintner K, Lincoln SE, Kusumi K, Bunker RK, Mao Y-P, Ganten D, Dzau VI, Lander ES. Genetic mapping of a gene causing hypertension in the stroke prone spontaneously hypertensive rat. Cell. 1991;87:213-224.
12. Luft FC, Miller JZ, Weinberger MH, Grim CE, Daugherty SA, Christian JC. Influence of genetic variance on sodium sensitivity of blood pressure. Klin Wochenschr. 1987;65:101-109.
13. Luft FC, Grim CE, Fineberg N, Weinberger MH. Effects of volume expansion and contraction in normotensive whites, blacks and subjects of different ages. Circulation. 1979;56:643-650.
14. Williams GH, Hollenberg NK. Non-modulating hypertension: a subset of sodium sensitive hypertension. Hypertension. 1991; 17(suppl I):I-81-I-85.
15. Moore TJ, Williams GH, Dluhy RG, Bavli SZ, Hinathongkan T, Greenfield M. Altered renin-angiotensin-aldosterone relationships in normal renin essential hypertension. Circ Res. 1977;41:167-171.
16. Ramírez AJ, Giménez MI, Gallo J, Marcó EJ, Sánchez RA. Renal sodium handling abnormalities in hypertensives and normotensive patients with a family history of hypertension. J Hypertens. 1989; 7(suppl 7):S19-S20.
17. Blackshear JL, Garnie D, Williams GH, Harrington DP, Hollenberg NK. Exaggerated renal vasodilator response to calcium entry blockade in first-degree relatives of essential hypertensive subjects. Hypertension. 1987;9:384-389.
18. Lifton RP, Hopkins PN, Williams RR, Hollenberg NK, Williams GH. Evidence for heritability of non-modulating essential hypertension. Hypertension. 1989;13:884-889.
19. Redgrave J, Canessa M, Gleason R, Hollenberg NK, Williams GH. Red blood cell lithium sodium countertransport in non-modulating essential hypertension. Hypertension. 1989;13:721-726.
20. Weder AB. Cation transport markers as predictors of hypertension. Am J Hypertens. 1991;4:633s-637s.
21. Taylor T, Moore TJ, Hollenberg NK, Williams GH. Converting enzyme inhibition corrects the altered adrenal response to angiotensin II in essential hypertension. Hypertension. 1984;6:92-99.
22. Redgrave J, Rabinowe S, Hollenberg NK, Williams GH. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives. J Clin Invest. 1985;75:1285-1290.
23. Ramírez AJ, Migliorini M, Gilbert BH, Marcó EJ, Sánchez RA. Non-modulating essential hypertension: renal hemodynamic effects of long term angiotensin converting enzyme inhibition. J Hypertens. 1991;6(suppl 6):396-397.
24. Schnurr E, Lahma W, Kuppers H. Measurements of renal clearance of inulin and PAH in the steady-state without urine collection. Clin Nephrol. 1980;13:26-29.
25. Deutsch E. Mitteilung zur nierenclearance: Eine einfache method zur quantitativen bestimmung der lavelose und des inulins im harn und in serum. Klin Med. 1949;4:81-85.
26. Smith H, Goldring W, Chasis H. The measurement of the tubular excretory mass, effective blood flow and filtration rate in the normal human kidney. J Clin Invest. 1938;17:263-266.
27. Canessa M, Adragna N, Solomon HS, Connolly TM, Tosteson DC. Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Engl J Med. 1980;302:772-776.
28. + exchanges. Methods Enzymol. 1989;173:176-191.
29. Labonia WD, Morelli OH Jr, Giménez MI, Freuler PV, Morelli OH. Effects of L-carnitine on sodium transport in erythrocytes from dialyzed uremic patients. Kidney Int. 1987;32:754-759.
30. Firth JD, Raine AEG, Ledingham JGG. The mechanism of pressure natriuresis. J Hypertens. 1990;8:97-103.
31. Romero JC, Knox FG. Mechanisms underlying pressure related systems: state-of-the-art lecture. Hypertension. 1988;11:724-738.
32. Cowley AW Jr. Long term control of arterial blood pressure. Physiol Rev. 1992;72:231-300.
33. Granger JP. Pressure natriuresis: role of renal interstitial hydrostatic pressure. Hypertension. 1992;19(suppl I):I-9-I-19.
34. Garcia-Esteban J, Roman RJ. Role of renal interstitial hydrostatic pressure in the pressure-diuresis response. Am J Physiol. 1989;256: F63-F70.
35. Gordon MS, Gordon MB, Hollenberg NK, Williams GH. Non-modulating trait may precede the development of hypertension. Am J Hypertens. 1994;7:789-793.
36. Oshima T, Matsura H, Matsumoto K, Kido K, Kajiyama G. Role of cellular calcium in salt sensitivity of patients with essential hypertension. Hypertension. 1988;11:703-707.
37. De la Sierra A, Insar R, Compte M, Martinez-Amendos A, Sierra C, Hernandez-Herrera G, Coca A. Effect of long term antihypertensive therapy with angiotensin converting enzyme inhibitors on red cell sodium transport. Am J Hypertens. 1995;8:622-625.
38. Karlberg BE, Ohman KP, Nilsson OR, Wettre S. Captopril lowers urinary kallikrein in hypertensive patients. Lancet. 1980;1:150-151.
39. + exchange decreases the affinity of sodium sites. Kidney Int. 1994;46:365-375.
40. - cotransport activity by enalapril. Hypertension. 1991;17:334-339.
41. - cotransport system in urine from salt-loaded rats. J Hypertens. 1993;11(suppl 5):S266-S267.